1

EPISODE · Apr 24, 2026 · 15 MIN

FDA Unlocks Gene Therapy For Hearing Loss, Signaling Shift in Rare Disease Treatment

from 1nessAgency Insights

The FDA just approved a gene therapy for genetic hearing loss in 61 days—tied for the fastest biologics license application approval in modern agency history. For healthcare marketers in the rare disease and precision medicine space, this velocity changes patient identification timelines, reimbursem

Episode metadata supplied by the publisher feed · Published Apr 24, 2026

Embed this episode

NOW PLAYING

FDA Unlocks Gene Therapy For Hearing Loss, Signaling Shift in Rare Disease Treatment

0:00 15:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of 1nessAgency Insights?

This episode is 15 minutes long.

When was this 1nessAgency Insights episode published?

This episode was published on April 24, 2026.

Can I download this 1nessAgency Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!